9/27/17 21:41 | 9/25/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S | -949 | 179.66 | 0 | -5 | -17 | 26 | D | | | | | | | | | | | | | | |
7/6/17 18:15 | 7/3/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 69 | 6.89 | 0 | 10 | 90 | 21 | D | | | | | | | | | | | | | | |
7/6/17 18:15 | 7/3/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -1,043 | 104.32 | 0 | -10 | -32 | 21 | D | | | | | | | | | | | | | | |
3/2/17 06:09 | 3/1/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 124 | 6.89 | 33 | 18 | 586 | 21 | D | 24 | 56 | 37 | 65 | 67 | 52 | 46 | 51 | -6 | -5 | -2 | | | |
3/2/17 06:09 | 3/1/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -1,350 | 75.01 | 33 | -18 | -46 | 21 | D | 24 | 56 | 37 | 65 | 67 | 52 | 46 | 51 | -6 | -5 | -2 | | | |
2/6/17 16:36 | 2/1/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 10 | 6.89 | 33 | 2 | 8 | 21 | D | -16 | 12 | -9 | 25 | 8 | 7 | 8 | 4 | -1 | -1 | 40 | 54 | | |
2/6/17 16:36 | 2/1/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -77 | 51.21 | 33 | -2 | -7 | 21 | D | -16 | 12 | -9 | 25 | 8 | 7 | 8 | 4 | -1 | -1 | 40 | 54 | | |
1/10/17 17:04 | 1/6/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 10 | 6.89 | 33 | 2 | 8 | 21 | D | -27 | -4 | 9 | -7 | 3 | 0 | 12 | 6 | -5 | -8 | 1 | 52 | | |
1/10/17 17:04 | 1/6/17 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -75 | 50.00 | 33 | -2 | -7 | 21 | D | -27 | -4 | 9 | -7 | 3 | 0 | 12 | 6 | -5 | -8 | 1 | 52 | | |
12/22/16 16:53 | 12/20/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S | -36 | 50.86 | 33 | -1 | -5 | 15 | D | -9 | -21 | -8 | -11 | -1 | -4 | 2 | -6 | 4 | -2 | 4 | 63 | | |
12/5/16 19:03 | 12/1/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 10 | 6.89 | 33 | 2 | 5 | 32 | D | 19 | -30 | -12 | -14 | 8 | -1 | -2 | 4 | -5 | -15 | -9 | 41 | | |
12/5/16 19:03 | 12/1/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -76 | 50.76 | 33 | -2 | -5 | 32 | D | 19 | -30 | -12 | -14 | 8 | -1 | -2 | 4 | -5 | -15 | -9 | 41 | | |
11/14/16 18:55 | 11/10/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 10 | 6.89 | 33 | 2 | 10 | 16 | D | 24 | -35 | 14 | -18 | -7 | 11 | 22 | 13 | -3 | -1 | -11 | 4 | | |
11/14/16 18:55 | 11/10/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -75 | 50.18 | 33 | -2 | -9 | 16 | D | 24 | -35 | 14 | -18 | -7 | 11 | 22 | 13 | -3 | -1 | -11 | 4 | | |
10/5/16 19:44 | 10/3/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 10 | 6.89 | 33 | 2 | 10 | 16 | D | 58 | -12 | 2 | 6 | -9 | 0 | 0 | -2 | -1 | -2 | -26 | -14 | 33 | |
10/5/16 19:44 | 10/3/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -82 | 54.81 | 33 | -2 | -9 | 16 | D | 58 | -12 | 2 | 6 | -9 | 0 | 0 | -2 | -1 | -2 | -26 | -14 | 33 | |
9/2/16 18:34 | 9/1/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 10 | 6.89 | 33 | 2 | 10 | 16 | D | 125 | 8 | 8 | 13 | 16 | -2 | -2 | 1 | 2 | -3 | -6 | -14 | 26 | |
9/2/16 18:34 | 9/1/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -87 | 58.24 | 33 | -2 | -9 | 16 | D | 125 | 8 | 8 | 13 | 16 | -2 | -2 | 1 | 2 | -3 | -6 | -14 | 26 | |
8/2/16 18:51 | 8/1/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 10 | 6.89 | 33 | 2 | 11 | 15 | D | 143 | -22 | 16 | 19 | 12 | 21 | 14 | 5 | 6 | 4 | 5 | -20 | -9 | |
8/2/16 18:51 | 8/1/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -85 | 56.90 | 33 | -2 | -9 | 15 | D | 143 | -22 | 16 | 19 | 12 | 21 | 14 | 5 | 6 | 4 | 5 | -20 | -9 | |
7/5/16 18:27 | 7/1/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 10 | 6.89 | 33 | 2 | 11 | 15 | D | 79 | -22 | -17 | 1 | 8 | 0 | 0 | 0 | 0 | -7 | 9 | 9 | -13 | |
7/5/16 18:27 | 7/1/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -75 | 50.00 | 33 | -2 | -9 | 15 | D | 79 | -22 | -17 | 1 | 8 | 0 | 0 | 0 | 0 | -7 | 9 | 9 | -13 | |
6/2/16 17:15 | 5/31/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.dm | 21 | 6.89 | 30 | 3 | 25 | 15 | D | | -8 | -38 | -5 | 4 | 18 | 8 | 6 | -5 | 3 | -9 | 8 | -11 | |
6/2/16 17:15 | 5/31/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.dm | -152 | 50.65 | 30 | -3 | -17 | 15 | D | | -8 | -38 | -5 | 4 | 18 | 8 | 6 | -5 | 3 | -9 | 8 | -11 | |
3/17/16 21:15 | 3/15/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 62 | 6.89 | 33 | 9 | 153 | 15 | D | | -31 | -31 | -31 | -4 | -2 | -18 | -13 | -1 | -5 | 13 | 18 | 23 | 90 |
3/17/16 21:15 | 3/15/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -404 | 44.88 | 33 | -9 | -38 | 15 | D | | -31 | -31 | -31 | -4 | -2 | -18 | -13 | -1 | -5 | 13 | 18 | 23 | 90 |
2/18/16 20:34 | 2/16/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 62 | 6.89 | 33 | 9 | 190 | 14 | D | | -22 | -20 | -41 | -23 | -1 | 16 | 17 | 3 | -4 | -5 | -6 | 31 | 18 |
2/18/16 20:34 | 2/16/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -397 | 44.07 | 33 | -9 | -40 | 14 | D | | -22 | -20 | -41 | -23 | -1 | 16 | 17 | 3 | -4 | -5 | -6 | 31 | 18 |
1/19/16 20:24 | 1/15/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 62 | 6.89 | 33 | 9 | 190 | 14 | D | | -23 | -24 | -14 | -24 | -11 | -3 | 2 | 2 | -9 | -12 | -13 | -12 | -14 |
1/19/16 20:24 | 1/15/16 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -497 | 55.26 | 33 | -9 | -40 | 14 | D | | -23 | -24 | -14 | -24 | -11 | -3 | 2 | 2 | -9 | -12 | -13 | -12 | -14 |
12/17/15 19:33 | 12/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 62 | 6.89 | 33 | 9 | | 6 | D | | 27 | 9 | 4 | -9 | -24 | -7 | 2 | -1 | -1 | -14 | -29 | -21 | -22 |
12/17/15 19:33 | 12/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -574 | 63.78 | 33 | -9 | -59 | 6 | D | | 27 | 9 | 4 | -9 | -24 | -7 | 2 | -1 | -1 | -14 | -29 | -21 | -22 |
11/18/15 19:31 | 11/16/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 62 | 6.89 | 33 | 9 | | 6 | D | | 98 | 54 | 43 | 24 | 12 | 8 | 0 | -3 | -2 | -29 | -48 | -52 | -46 |
11/18/15 19:31 | 11/16/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -703 | 78.08 | 33 | -9 | -59 | 6 | D | | 98 | 54 | 43 | 24 | 12 | 8 | 0 | -3 | -2 | -29 | -48 | -52 | -46 |
10/19/15 19:29 | 10/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | M.d | 62 | 6.89 | 33 | 9 | | 6 | D | | 100 | 11 | -11 | 20 | 21 | 1 | 9 | -1 | 4 | 18 | -20 | -33 | -28 |
10/19/15 19:29 | 10/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | SVP Clin | S.d | -563 | 62.59 | 33 | -9 | -59 | 6 | D | | 100 | 11 | -11 | 20 | 21 | 1 | 9 | -1 | 4 | 18 | -20 | -33 | -28 |
9/17/15 20:01 | 9/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | M.d | 62 | 6.89 | 33 | 9 | | 6 | D | | 135 | 0 | 7 | -17 | 23 | 17 | -1 | 3 | -4 | 1 | 0 | -31 | -14 |
9/17/15 20:01 | 9/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | S.d | -579 | 64.34 | 33 | -9 | -59 | 6 | D | | 135 | 0 | 7 | -17 | 23 | 17 | -1 | 3 | -4 | 1 | 0 | -31 | -14 |
8/19/15 20:04 | 8/17/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | M.d | 62 | 6.89 | 33 | 9 | | 5 | D | | 154 | -8 | 13 | -4 | -18 | -16 | -3 | -9 | -10 | 14 | 40 | -16 | 7 |
8/19/15 20:04 | 8/17/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | S.d | -548 | 60.87 | 33 | -9 | -63 | 5 | D | | 154 | -8 | 13 | -4 | -18 | -16 | -3 | -9 | -10 | 14 | 40 | -16 | 7 |
7/20/15 21:03 | 7/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | M.d | 62 | 6.89 | 33 | 9 | | 5 | D | | 227 | 1 | 12 | 18 | 21 | 20 | 5 | -3 | -6 | -17 | -12 | -24 | -33 |
7/20/15 21:03 | 7/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | S.d | -647 | 71.92 | 33 | -9 | -63 | 5 | D | | 227 | 1 | 12 | 18 | 21 | 20 | 5 | -3 | -6 | -17 | -12 | -24 | -33 |
6/17/15 19:19 | 6/25/14 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | P.d | 68 | 17.00 | 33 | 4 | 328 | 5 | D | | | 8 | -7 | 10 | 11 | -5 | 1 | 3 | 6 | 26 | 8 | 8 | -11 |
6/17/15 19:19 | 6/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | M.d | 62 | 6.89 | 33 | 9 | | 5 | D | | | 8 | -7 | 10 | 11 | -5 | 1 | 3 | 6 | 26 | 8 | 8 | -11 |
6/17/15 19:19 | 6/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | S.d | -513 | 57.00 | 33 | -9 | -63 | 5 | D | | | 8 | -7 | 10 | 11 | -5 | 1 | 3 | 6 | 26 | 8 | 8 | -11 |
5/19/15 20:01 | 5/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | M.d | 62 | 6.89 | 33 | 9 | | 1 | D | | | 14 | -25 | -17 | -16 | -17 | -16 | 1 | 0 | 16 | 19 | 65 | -17 |
5/19/15 20:01 | 5/15/15 | KITE | Kite Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiezorek Jeffrey | CA | O | VP Clini | S.d | -451 | 50.15 | 33 | -9 | -88 | 1 | D | | | 14 | -25 | -17 | -16 | -17 | -16 | 1 | 0 | 16 | 19 | 65 | -17 |